A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod

Derek W. Stitt; Christopher J. Boes; Eoin P. Flanagan; Matthew T. Howard; Joseph P. Colgan

doi:10.1016/j.msard.2017.11.014

A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod

Derek W. Stitt, Christopher J. Boes, Eoin P. Flanagan, Matthew T. Howard, Joseph P. Colgan

Neurology

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The authors report a case of a 69-year-old woman with multiple sclerosis treated with fingolimod for duration of over one year who subsequently developed cutaneous large B cell lymphoma. There are few reported cases of lymphoma associated with fingolimod treatment for multiple sclerosis, but rates are higher than expected in the general population. The authors hope to promote awareness of the potential risk of this medication so that more diligent disease surveillance can be performed by both prescribing practitioners of fingolimod and their patients who receive it.

Original language	English (US)
Pages (from-to)	115-117
Number of pages	3
Journal	Multiple Sclerosis and Related Disorders
Volume	19
DOIs	https://doi.org/10.1016/j.msard.2017.11.014
State	Published - Jan 2018

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1016/j.msard.2017.11.014

Cite this

@article{d07500b4a0fa4af3b6842c6347f1eff7,

title = "A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod",

abstract = "The authors report a case of a 69-year-old woman with multiple sclerosis treated with fingolimod for duration of over one year who subsequently developed cutaneous large B cell lymphoma. There are few reported cases of lymphoma associated with fingolimod treatment for multiple sclerosis, but rates are higher than expected in the general population. The authors hope to promote awareness of the potential risk of this medication so that more diligent disease surveillance can be performed by both prescribing practitioners of fingolimod and their patients who receive it.",

author = "Stitt, {Derek W.} and Boes, {Christopher J.} and Flanagan, {Eoin P.} and Howard, {Matthew T.} and Colgan, {Joseph P.}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier B.V.",

year = "2018",

month = jan,

doi = "10.1016/j.msard.2017.11.014",

language = "English (US)",

volume = "19",

pages = "115--117",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier",

}

TY - JOUR

T1 - A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod

AU - Stitt, Derek W.

AU - Boes, Christopher J.

AU - Flanagan, Eoin P.

AU - Howard, Matthew T.

AU - Colgan, Joseph P.

PY - 2018/1

Y1 - 2018/1

N2 - The authors report a case of a 69-year-old woman with multiple sclerosis treated with fingolimod for duration of over one year who subsequently developed cutaneous large B cell lymphoma. There are few reported cases of lymphoma associated with fingolimod treatment for multiple sclerosis, but rates are higher than expected in the general population. The authors hope to promote awareness of the potential risk of this medication so that more diligent disease surveillance can be performed by both prescribing practitioners of fingolimod and their patients who receive it.

AB - The authors report a case of a 69-year-old woman with multiple sclerosis treated with fingolimod for duration of over one year who subsequently developed cutaneous large B cell lymphoma. There are few reported cases of lymphoma associated with fingolimod treatment for multiple sclerosis, but rates are higher than expected in the general population. The authors hope to promote awareness of the potential risk of this medication so that more diligent disease surveillance can be performed by both prescribing practitioners of fingolimod and their patients who receive it.

UR - http://www.scopus.com/inward/record.url?scp=85035004316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035004316&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2017.11.014

DO - 10.1016/j.msard.2017.11.014

M3 - Article

C2 - 29190574

AN - SCOPUS:85035004316

SN - 2211-0348

VL - 19

SP - 115

EP - 117

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

ER -

A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this